上市公司数据是反映行业发展状况的重要指标。本文依据25家医药流通行业上市公司公开披露的2019年年报资料,分析其收入增长、盈利水平、费用控制、资本运作和战略实施的情况,揭示2019年国内医药流通行业上市公司的现状,并试图发现一些行业变迁的新趋势。医药政策的渐次推进、资本的催生作用、新一代信息及时应用,都对医药流通行业产生巨大影响。医药流通企业一定要保持战略定力,积极进行结构调整和产业升级,并努力保持高质量发展。
<<The data of listed companies are an important indicator of the development of the industry. According to the annual report data of 25 listed companies in the pharmaceutical distribution industry in 2019,this paper analyzes their revenue growth,profitability,expense control,capital operation and strategy implementation in an attempt to find some new trends in the development of the industry. The gradual advancement of pharmaceutical policies,the stimulating role of capital,and the timely application of new generation information have all had a huge impact on the pharmaceutical distribution industry. Pharmaceutical distribution enterprises must maintain their strategic strength,actively carry out structural adjustment and industrial upgrading,and strive to maintain high-quality development.
<<